{"chunk_id": "_Drugs-in-Pregnancy-and-Lactation--Improved-Benefit-Risk-Information_-January-22--2015-Issue__chunk_14", "source": "_Drugs-in-Pregnancy-and-Lactation--Improved-Benefit-Risk-Information_-January-22--2015-Issue", "text": "gs when those drugs are used by pregnant women to treat a medical \ncondition. \nWhy: You may be asking why FDA has now decided to change this system when it has be en in place for decades.  This rulemaking \nis part of a broad effort by the Agency to improve the content and format of prescription drug labeling. The PLLR amends the \nPhysician Labeling Rule (PLR) that deferred revisions to these subsections when the PLR w as published in 2006. FDA obtained \nextensive stakeholder input as part of the"}